UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Gabelli Equity Trust
GAB
$1.79B
| $1.7M | ﹤0.01% |
327,703
-91,631
| -22% | -$494K |
|
3927
CALL
Zimmer Biomet
ZBH
$18.7B
| $1.7M | ﹤0.01% |
15,700
-4,600
| -23% | -$542K |
|
|
3928
PUT
Zimmer Biomet
ZBH
$18.7B
| $1.7M | ﹤0.01% |
15,700
-4,600
| -23% | -$542K |
|
3929
Star Bulk Carriers
SBLK
$3.17B
| $1.7M | ﹤0.01% |
69,886
+39,172
| +128% | +$974K |
|
3930
Invesco Bond Fund
VBF
$168M
| $1.7M | ﹤0.01% |
106,021
-5,044
| -5% | -$78.8K |
|
3931
MasterBrand
MBC
$1.84B
| $1.7M | ﹤0.01% |
115,716
-18,215
| -14% | -$302K |
|
3932
CareTrust REIT
CTRE
$9.55B
| $1.7M | ﹤0.01% |
67,534
-57,834
| -46% | -$1.43M |
|
3933
B2Gold
BTG
$6.68B
| $1.69M | ﹤0.01% |
627,738
-173,486
| -22% | -$468K |
|
3934
Greif
GEF
$4.97B
| $1.69M | ﹤0.01% |
29,488
-102,268
| -78% | -$6.46M |
|
3935
Oxford Industries
OXM
$556M
| $1.69M | ﹤0.01% |
16,911
-57,732
| -77% | -$6.09M |
|
3936
Tompkins Financial
TMP
$1.4B
| $1.69M | ﹤0.01% |
34,613
-2,536
| -7% | -$117K |
|
3937
CALL
Plug Power
PLUG
$2.94B
| $1.69M | ﹤0.01% |
726,000
+76,000
| +12% | +$218K |
|
3938
Tronox
TROX
$993M
| $1.69M | ﹤0.01% |
107,767
-67,268
| -38% | -$1.22M |
|
|
STK
3939
Columbia Seligman Premium Technology Growth Fund
STK
$923M
| $1.69M | ﹤0.01% |
50,651
+2,846
| +6% | +$90.6K |
|
3940
CALL
Mobileye
MBLY
$7.44B
| $1.69M | ﹤0.01% |
60,000
-40,000
| -40% | -$1.16M |
|
3941
CALL
Veritone
VERI
$134M
| $1.68M | ﹤0.01% |
744,760
| – | – |
|
3942
Comstock Resources
CRK
$4.22B
| $1.68M | ﹤0.01% |
161,693
-196,013
| -55% | -$2.05M |
|
3943
Capitol Federal Financial
CFFN
$1.08B
| $1.67M | ﹤0.01% |
304,698
+147,238
| +94% | +$767K |
|
|
EWCZ
3944
DELISTED
European Wax Center
EWCZ
| $1.67M | ﹤0.01% |
168,315
-10,102
| -6% | -$115K |
|
3945
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.73B
| $1.67M | ﹤0.01% |
20,626
+2,036
| +11% | +$162K |
|
3946
Ericsson
ERIC
$32.7B
| $1.67M | ﹤0.01% |
270,518
-287,976
| -52% | -$1.61M |
|
3947
Harmony Biosciences
HRMY
$2.27B
| $1.67M | ﹤0.01% |
55,300
-58,177
| -51% | -$1.75M |
|
|
AKRO
3948
DELISTED
Akero Therapeutics
AKRO
| $1.67M | ﹤0.01% |
71,111
-136,890
| -66% | -$2.93M |
|
3949
CALL
Stryker
SYK
$133B
| $1.67M | ﹤0.01% |
4,900
+2,000
| +69% | +$677K |
|
3950
PUT
Lumen
LUMN
$6.85B
| $1.66M | ﹤0.01% |
1,512,100
-300,000
| -17% | -$380K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.